March 18, 2013
March 18, 2013 —
Three UC San Diego School of Medicine chairs receive recognition from the American College of Psychiatrists, The American College of Radiation Oncology, and The American Glaucoma Soceity.
October 15, 2012
October 15, 2012 —
The Institute of Medicine (IOM) today announced the names of 70 new members and 10 foreign associates during its 42nd annual meeting. Included are two new members from the University of California, San Diego School of Medicine: David A. Brenner, MD, vice chancellor for Health Sciences and dean of the UCSD School of Medicine, and Don W. Cleveland, PhD, chair of the UCSD Department of Cellular and Molecular Medicine, and professor of medicine, neurosciences, and cellular and molecular medicine at the Ludwig Institute for Cancer Research.
April 30, 2012
April 30, 2012 —
William G. Bradley, Jr., MD, PhD, FACR, chairman of the Department of Radiology, was awarded the ACR Gold Medal and Honorary Fellowship, the highest honor of the American College of Radiology on April 22, during the ACR annual meeting and Chapter Leadership Conference held in Washington, D.C. The ACR said of Bradley, “(He) is renowned for his endless dedication…to advance the science and cause of radiology locally, nationally and internationally.”
October 18, 2011
October 18, 2011 —
Every year, millions of patients undergo lifesaving surgeries. The outcome of each procedure is driven by dynamic factors such as the patient’s health, drugs and instruments used, team communication, and the wisdom of the surgeon’s hand. To advance safety and innovation in today’s operating rooms, the School of Medicine at the University of California, San Diego has unveiled the Center for the Future of Surgery (CFoS) ─ the largest state-of-the art facility in the nation dedicated to catalyzing novel surgical technologies, techniques and teaching methods.
October 13, 2011
October 13, 2011 —
A collaborative partnership between the UC San Diego Liver Center and Antiviral Research Center (AVRC) has resulted in 19 clinical trials for hepatitis C virus (HCV), focused on developing more effective and well-tolerated HCV treatments.
